Can you provide the average price target for NANOBIOTIX stock?
12 analysts have analysed NANO.PA and the average price target is 29.1 EUR. This implies a price increase of 3.5% is expected in the next year compared to the current price of 28.12.
EPA:NANO • FR0011341205
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NANOBIOTIX (NANO.PA).
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30.058M | -11.609M -138.62% | 7.843M 167.56% | 51.551M 557.29% | 51.529M -0.04% | 121.46M 135.71% | 57.26M -52.86% | 126.75M 121.36% | 282.97M 123.25% | 385.99M 36.41% | 614.92M 59.31% | |
| EBITDA YoY % growth | -25.266M 44.10% | -66.771M -164.27% | -31.123M 53.39% | -18.947M 39.12% | 816K 104.31% | -339.997K -141.67% | -44.059M -12,858.56% | 171.76M 489.84% | 74.011M -56.91% | 112.08M 51.44% | N/A | |
| EBIT YoY % growth | -26.779M 42.66% | -68.392M -155.39% | -32.618M 52.31% | -8.936M 72.60% | 510.612K 105.71% | 9.689M 1,797.53% | -12.294M -226.89% | 48.205M 492.10% | 161.7M 235.44% | 249.92M 54.56% | 462.73M 85.15% | |
| Operating Margin | -89.09% | 589.13% | -415.89% | -17.33% | 0.99% | 7.98% | -21.47% | 38.03% | 57.14% | 64.75% | 75.25% | |
| EPS YoY % growth | -1.08 24.32% | -1.44 -33.33% | -0.50 65.28% | -0.62 -24.95% | -0.45 28.57% | -0.01 97.71% | -0.18 -1,691.00% | 1.67 1,015.52% | 2.24 34.13% | 2.71 20.98% | N/A |
All data in EUR
| Q2 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.14 -29.82% | 1.01 358.92% |
| Revenue Q2Q % growth | 23.868M -10.40% | 94.86M 1,492.95% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
12 analysts have analysed NANO.PA and the average price target is 29.1 EUR. This implies a price increase of 3.5% is expected in the next year compared to the current price of 28.12.
NANOBIOTIX (NANO.PA) will report earnings on 2026-05-19.
The consensus EPS estimate for the next earnings of NANOBIOTIX (NANO.PA) is -0.14 EUR and the consensus revenue estimate is 23.87M EUR.
The consensus rating for NANOBIOTIX (NANO.PA) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.